AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese

Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)

Abstract

Prophylactic human papilloma virus (HPV) vaccination is an effective strategy to prevent HPV infection and reduce the incidence of HPV-related diseases.Current clinical trials and real-world studies globally have demonstrated that prophylactic HPV vaccines are safe, immunogenic, and exhibit robust protective efficacy and effectiveness.Priority vaccination is recommended for females aged 9-26 years, with a focus on girls aged 9-14 years.Additionally, vaccination is advised for females aged 27-45 years and males aged 9-26 years to promote gender-neutral prevention strategies.Prophylactic HPV vaccination is also recommended for high-risk and special populations, including individuals with HPV infection or cytological abnormalities, those with a history of HPV-related lesions, genetically susceptible populations, individuals with high-risk lifestyle behaviors associated with cervical cancer, and immunocompromised patients.Regular cervical cancer screening remains essential post-vaccination.

CLC number: R271.1;R711.74 Document code: A Article ID: 1674-9081(2025)02-0350-11

References

【1】
【1】
 
 
Medical Journal of Peking Union Medical College Hospital
Pages 350-360

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition). Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 350-360. https://doi.org/10.12290/xhyxzz.2025-0246

3038

Views

32

Downloads

0

Crossref

7

Scopus

11

CSCD

Received: 17 March 2025
Accepted: 17 March 2025
Published: 31 March 2025
© 2025 Medical Journal of Peking Union Medical College Hospital